LIPO-CWeight Loss / GLP-1
Lipotropic (MIC) blend studied for fat-metabolism support.
- Status
- Research / not approved
- Developer
- Compounding-pharmacy formulation; no single developer; marketed by weight-loss / aesthetic clinics
- Receptors / target
- Not a single target; components support hepatic lipid/methyl metabolism — choline & methionine (methyl donors / VLDL export), inositol (signaling), often L-carnitine (fatty-acid transport) and B12
- FDA-approved?
- NO
- Prescription available?
- NO
- Studied for
- hepatic lipid metabolism & fatty liver (component biochemistry)one-carbon / methyl-donor metabolismweight-loss / fat-reduction marketing claims (unsubstantiated)nutrient (choline, methionine, B12) repletion
Overview
Lipo-C is not a single molecule — it is a compounded "lipotropic" (fat-burner) injection, a mixture prepared by compounding pharmacies and marketed mainly by weight-loss and aesthetic clinics. Its core is the "MIC" combination — methionine, inositol and choline — and many blends add L-carnitine and/or vitamin B12. Because the recipe and doses vary by pharmacy, there is no fixed molecular formula, CAS or PubChem entry for "Lipo-C." The marketing premise is that these nutrients are "lipotropic" (aiding hepatic fat handling) and so promote weight loss — a leap that is not supported by controlled evidence. It is a compounded product, not an FDA-approved weight-loss drug.
Mechanism
The proposed mechanism is built from the real biochemistry of the separate ingredients. Choline is needed to make phosphatidylcholine, which packages triglycerides into VLDL for export from the liver (deficiency causes fatty liver). Methionine feeds one-carbon metabolism and S-adenosylmethionine, the universal methyl donor. Inositol participates in cell signaling. Added L-carnitine shuttles long-chain fatty acids into mitochondria for beta-oxidation, and B12 supports one-carbon metabolism. The critical caveat: each mechanism describes how the nutrient works when deficient and then repleted — none establishes that injecting these nutrients into a non-deficient person increases net fat loss.
Clinical evidence
There is no good clinical-trial evidence that MIC/lipotropic injections cause weight loss or fat reduction. Human trials of the injection itself are scarce, and supporting claims are largely anecdotal; any weight loss reported by clinics typically occurs alongside calorie restriction and lifestyle change, which confounds attribution. The genuine evidence concerns the individual nutrients' biochemistry — choline's role in liver lipid export, carnitine's role in fatty-acid oxidation — in deficiency states or cell/animal models, not the injected mixture as a fat-loss intervention. Efficacy of the marketed injection is unproven.
Safety profile
The constituent nutrients (choline, methionine, inositol, L-carnitine, B12) are generally well tolerated at customary intakes — the NIH sets a choline upper limit of 3,500 mg/day. The most common practical issues are injection-site reactions and GI upset, plus component-specific effects (fishy odor with high choline) and possible hypersensitivity. The larger concern is structural: Lipo-C is an unstandardized, compounded injectable whose potency, dose, sterility and quality vary by pharmacy, and it is not an FDA-approved drug. Despite aggressive "fat-burner" marketing there is no reliable evidence it melts fat; it should not be presented as a proven weight-loss treatment. Research-use framing; not medical advice.
- Per injection
Given as weekly IM/SC shots in weight-loss clinics, but no controlled trial shows the MIC injection itself causes weight or fat loss.
- Reality
Any results typically track the accompanying diet/exercise; there is no proven independent time-course for the injection.
Reported in published literature and user reports. Not a complete list, and not medical advice.
- Injection-site reactions (pain, redness, swelling, bruising)
- Gastrointestinal upset (nausea, cramping, diarrhea)
- Component-dependent effects (fishy body odor with high choline; flushing)
- Hypersensitivity / allergic reaction to a component or preservative
If severe or unexpected symptoms occur, contact a qualified medical professional. PEPTIDES·INDEX does not provide medical advice.
- Human contraindication data for the Lipo-C product itself do not exist; cautions are inferred from components
- Avoid with known hypersensitivity to choline, methionine, inositol, L-carnitine, B12 or any preservative in the compound
- Choline has a tolerable upper intake level of 3,500 mg/day; high choline intake can cause fishy body odor and GI effects
- No documented human drug interactionsInteraction profile uncharacterized in humans (research use only)
Compare
- vs Lipo-B
Lipo-B is the same MIC base built around added B12 rather than L-carnitine; both are unproven for weight loss.
- vs L-Carnitine
L-carnitine is a single, FDA-approved (as levocarnitine) component often added to Lipo-C and is far better characterized than the blend.
FAQ
Do Lipo-C (MIC) injections cause weight loss?
There is no good clinical-trial evidence that they do. Lipo-C is a compounded methionine-inositol-choline mixture; any weight loss reported by clinics typically tracks the accompanying diet and exercise, which confounds attribution. It should not be presented as a proven weight-loss treatment.
What is actually in Lipo-C?
Its core is the MIC trio — methionine, inositol and choline — and many blends add L-carnitine and/or vitamin B12. Because it is compounded, the exact recipe, doses and quality vary by pharmacy, and there is no fixed formula or CAS number.
Is Lipo-C FDA-approved?
No. It is an unstandardized compounded injectable that is not FDA-reviewed for efficacy, potency, sterility or purity, and it is not an approved weight-loss drug.
How is Lipo-C different from Lipo-B?
Both share the MIC base (methionine, inositol, choline). Lipo-C typically adds L-carnitine, while Lipo-B is built around added vitamin B12 (the 'B'). Neither is standardized, and neither has clinical-trial evidence for weight loss; the difference is which extra ingredient the pharmacy bolts on.
What are the side effects of Lipo-C?
The most common are injection-site reactions (pain, redness, bruising) and GI upset, plus component-specific effects such as a fishy body odor at high choline doses. The NIH sets a choline upper intake level of 3,500 mg/day. The bigger issue is structural — potency and sterility vary because it is a compounded product.
Is Lipo-C the same as a 'fat-burner'?
That is the marketing claim, not the evidence. The 'lipotropic' label refers to the ingredients' role in hepatic fat handling in deficiency states; it does not mean injecting them into a non-deficient person increases net fat loss. No controlled trial shows the injection itself burns fat.
Similar compounds
Starting references for the library summary. These are not dosing instructions or medical advice.
For research-use educational context only. Not medical advice and not a recommendation to use any compound. Consult a qualified healthcare professional before any health decision.